NETSAS
@netsas.bsky.social
Neuroendocrine Tumor Southern Africa Support. NETSAS provides support for NETs patients and empowers patients with knowledge
http://www.netsas.org.za
http://www.netsas.org.za
📌Join the amazing group of #PrimaryCarePhysicians from 35 countries worldwide who already completed the free online CME-accredited #ThinkNENs Global Educational Program for Primary Care Physicians!
✅Check here and enroll: incalliance.org/think-nens/ #LetsTalkAboutNETs
✅Check here and enroll: incalliance.org/think-nens/ #LetsTalkAboutNETs
May 20, 2025 at 8:40 PM
Reposted by NETSAS
📌Join the amazing group of #PrimaryCarePhysicians from 35 countries worldwide who already completed the free online CME-accredited #ThinkNENs Global Educational Program for Primary Care Physicians!
✅Check here and enroll: incalliance.org/think-nens/ #LetsTalkAboutNETs
✅Check here and enroll: incalliance.org/think-nens/ #LetsTalkAboutNETs
May 8, 2025 at 6:20 AM
📌Join the amazing group of #PrimaryCarePhysicians from 35 countries worldwide who already completed the free online CME-accredited #ThinkNENs Global Educational Program for Primary Care Physicians!
✅Check here and enroll: incalliance.org/think-nens/ #LetsTalkAboutNETs
✅Check here and enroll: incalliance.org/think-nens/ #LetsTalkAboutNETs
Reposted by NETSAS
📌Watch the NEW NET research video on the INCA website:
Dr. Mauro Cives presents the latest updates in translational NET research.
📌Watch the video: incalliance.org/dr-mauro-civ...
#LetsTalkAboutNETs
Dr. Mauro Cives presents the latest updates in translational NET research.
📌Watch the video: incalliance.org/dr-mauro-civ...
#LetsTalkAboutNETs
May 14, 2025 at 6:17 AM
📌Watch the NEW NET research video on the INCA website:
Dr. Mauro Cives presents the latest updates in translational NET research.
📌Watch the video: incalliance.org/dr-mauro-civ...
#LetsTalkAboutNETs
Dr. Mauro Cives presents the latest updates in translational NET research.
📌Watch the video: incalliance.org/dr-mauro-civ...
#LetsTalkAboutNETs
Delayed NEN diagnosis is a global challenge.
📌We help #PrimaryCarePhysicians to think more about the possibility of uncovering the NEN diagnosis and facilitating referral.
✅Enroll in the free CME-accredited program: incalliance.org/think-nens/
#LetsTalkAboutNETs
📌We help #PrimaryCarePhysicians to think more about the possibility of uncovering the NEN diagnosis and facilitating referral.
✅Enroll in the free CME-accredited program: incalliance.org/think-nens/
#LetsTalkAboutNETs
May 20, 2025 at 8:36 PM
📣Great opportunity to engage with your GP.
🙌 Make them aware of this invaluable resource, in our narrow experience it has been well received and highly appreciated!
#InternationalNeuroendocrineCancerAssociation
#LetsTalkAboutNETs
🙌 Make them aware of this invaluable resource, in our narrow experience it has been well received and highly appreciated!
#InternationalNeuroendocrineCancerAssociation
#LetsTalkAboutNETs
👏On the #WorldFamilyDoctorsDay, we would like to praise the key role #PrimaryCarePhysicians play in timely diagnosis and patient management.
📌Share with your family doctor the free #ThinkNENs e-learning program with CME credit in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
📌Share with your family doctor the free #ThinkNENs e-learning program with CME credit in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
May 20, 2025 at 8:35 PM
📣Great opportunity to engage with your GP.
🙌 Make them aware of this invaluable resource, in our narrow experience it has been well received and highly appreciated!
#InternationalNeuroendocrineCancerAssociation
#LetsTalkAboutNETs
🙌 Make them aware of this invaluable resource, in our narrow experience it has been well received and highly appreciated!
#InternationalNeuroendocrineCancerAssociation
#LetsTalkAboutNETs
Reposted by NETSAS
👏On the #WorldFamilyDoctorsDay, we would like to praise the key role #PrimaryCarePhysicians play in timely diagnosis and patient management.
📌Share with your family doctor the free #ThinkNENs e-learning program with CME credit in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
📌Share with your family doctor the free #ThinkNENs e-learning program with CME credit in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
May 19, 2025 at 6:43 AM
👏On the #WorldFamilyDoctorsDay, we would like to praise the key role #PrimaryCarePhysicians play in timely diagnosis and patient management.
📌Share with your family doctor the free #ThinkNENs e-learning program with CME credit in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
📌Share with your family doctor the free #ThinkNENs e-learning program with CME credit in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
🙌 Great work by @neuroendo-can-uk.bsky.social
🎥 New webinar recording now available: Bill Harris & Elena Vrana (The Christie) outline the purpose, phases & patient value of clinical trials in neuroendocrine cancer — incl. a case study & advocacy insights.
Watch here: youtu.be/DYBhHuFKhZM?...
Watch here: youtu.be/DYBhHuFKhZM?...
Understanding Research & Why it's So Important, Neuroendocrine Cancer UK April 2025 Webinar
YouTube video by Neuroendocrine Cancer UK
youtu.be
May 20, 2025 at 8:26 PM
🙌 Great work by @neuroendo-can-uk.bsky.social
Reposted by NETSAS
Gastrointestinal symptoms, such as nausea or vomiting, can be signs of #MultipleEndocrineNeoplasia type 1 (MEN1).
👉These symptoms can mislead clinicians if they do not suspect something less common.
✅Get to know MEN1 in 11 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
👉These symptoms can mislead clinicians if they do not suspect something less common.
✅Get to know MEN1 in 11 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
May 13, 2025 at 6:53 AM
Gastrointestinal symptoms, such as nausea or vomiting, can be signs of #MultipleEndocrineNeoplasia type 1 (MEN1).
👉These symptoms can mislead clinicians if they do not suspect something less common.
✅Get to know MEN1 in 11 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
👉These symptoms can mislead clinicians if they do not suspect something less common.
✅Get to know MEN1 in 11 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Reposted by NETSAS
📌Dr. Jaydira Del Rivero, Medical Oncologist and Endocrinologist at NCI: “We need patient-centric approach in NET research and to consider tolerability and quality of life of patients.”
✅Watch the video in 6 languages: incalliance.org/dr-jaydira-d...
#LetsTalkAboutNETs
✅Watch the video in 6 languages: incalliance.org/dr-jaydira-d...
#LetsTalkAboutNETs
April 28, 2025 at 8:33 AM
📌Dr. Jaydira Del Rivero, Medical Oncologist and Endocrinologist at NCI: “We need patient-centric approach in NET research and to consider tolerability and quality of life of patients.”
✅Watch the video in 6 languages: incalliance.org/dr-jaydira-d...
#LetsTalkAboutNETs
✅Watch the video in 6 languages: incalliance.org/dr-jaydira-d...
#LetsTalkAboutNETs
Reposted by NETSAS
📌Dr. Simron Singh, NEN expert on the #ThinkNENs Global Educational Program for PCPs: “Somatostatin analogues remain the mainstay of treatment for all NENs."
✅Enroll in the free CME-accredited e-learning in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
✅Enroll in the free CME-accredited e-learning in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
May 1, 2025 at 9:08 AM
📌Dr. Simron Singh, NEN expert on the #ThinkNENs Global Educational Program for PCPs: “Somatostatin analogues remain the mainstay of treatment for all NENs."
✅Enroll in the free CME-accredited e-learning in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
✅Enroll in the free CME-accredited e-learning in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
Reposted by NETSAS
In case you needed a reminder of the not-so-predictable somatostatin receptor expression of lung NETs, here you have it...
Keep in mind that only 44% had uniformly positive SSTR expression and some have none at all like this patient.
jnm.snmjournals.org/content/64/1...
Keep in mind that only 44% had uniformly positive SSTR expression and some have none at all like this patient.
jnm.snmjournals.org/content/64/1...
March 25, 2025 at 6:10 PM
In case you needed a reminder of the not-so-predictable somatostatin receptor expression of lung NETs, here you have it...
Keep in mind that only 44% had uniformly positive SSTR expression and some have none at all like this patient.
jnm.snmjournals.org/content/64/1...
Keep in mind that only 44% had uniformly positive SSTR expression and some have none at all like this patient.
jnm.snmjournals.org/content/64/1...
Reposted by NETSAS
Trying to summarize nuanced treatment decisions in one slide... What to do with small NF-pNETs? Who to observe? When to intervene...? What am I missing/getting wrong...?
April 9, 2025 at 1:29 PM
Trying to summarize nuanced treatment decisions in one slide... What to do with small NF-pNETs? Who to observe? When to intervene...? What am I missing/getting wrong...?
Such an important topic - thanks @oncothor.bsky.social
It is not all about tumor shrinkage after PRRT. In this NETTER-1 analysis, PFS and OS were not different in patients where tumor shrinkage was seen. Not a new observation but a topic I discuss every week with patients. Benefits can be seen w/o high ORR...
onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com/doi/10.1002/...
Relationship Between Best Tumor Shrinkage and Progression‐Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [177Lu]Lu‐DOTA‐TATE: Ad Hoc Analysis of the Phase III NETTER‐1 Trial
We analyzed data from the phase III NETTER-1 study of 177Lu‑DOTATATE for patients with advanced midgut neuroendocrine tumors to explore whether tumor shrinkage is associated with durable efficacy. Al...
onlinelibrary.wiley.com
May 1, 2025 at 9:48 AM
Such an important topic - thanks @oncothor.bsky.social
Including patients in the development of their treatment plans pathway leads to better outcomes. Patients that are empowered and feel heard typically respond better!
#LetsTalkAboutNETs #netsas
#LetsTalkAboutNETs #netsas
May 1, 2025 at 9:47 AM
Including patients in the development of their treatment plans pathway leads to better outcomes. Patients that are empowered and feel heard typically respond better!
#LetsTalkAboutNETs #netsas
#LetsTalkAboutNETs #netsas
Reposted by NETSAS
Still a little confused on the difference between grade and differentiation in panc NETs...? Need a quick primer on the pathology of pNETs including the genetic/molecular alterations. If so, Dr's. Rindi and Inzani have you covered.
meridian.allenpress.com/aplm/article...
meridian.allenpress.com/aplm/article...
Differentiation Versus Grade for Pancreatic Neuroendocrine Neoplasms
Context.—. Pancreatic neuroendocrine neoplasia (panNEN) is a tumor disease with distinctive morphology and often poses diagnostic challenges.Objective.—. To present and discuss the current diagnostic ...
meridian.allenpress.com
March 14, 2025 at 12:04 AM
Still a little confused on the difference between grade and differentiation in panc NETs...? Need a quick primer on the pathology of pNETs including the genetic/molecular alterations. If so, Dr's. Rindi and Inzani have you covered.
meridian.allenpress.com/aplm/article...
meridian.allenpress.com/aplm/article...
Reposted by NETSAS
It is not all about tumor shrinkage after PRRT. In this NETTER-1 analysis, PFS and OS were not different in patients where tumor shrinkage was seen. Not a new observation but a topic I discuss every week with patients. Benefits can be seen w/o high ORR...
onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com/doi/10.1002/...
Relationship Between Best Tumor Shrinkage and Progression‐Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [177Lu]Lu‐DOTA‐TATE: Ad Hoc Analysis of the Phase III NETTER‐1 Trial
We analyzed data from the phase III NETTER-1 study of 177Lu‑DOTATATE for patients with advanced midgut neuroendocrine tumors to explore whether tumor shrinkage is associated with durable efficacy. Al...
onlinelibrary.wiley.com
April 25, 2025 at 11:55 AM
It is not all about tumor shrinkage after PRRT. In this NETTER-1 analysis, PFS and OS were not different in patients where tumor shrinkage was seen. Not a new observation but a topic I discuss every week with patients. Benefits can be seen w/o high ORR...
onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com/doi/10.1002/...